Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

UT481

Endometrium cancer tissue array, including TNM and pathology grade, 48 cases/48 cores
Unstained: $195.00 Add to Cart
H&E (UT481s*): $195.00 Add to Cart

Microarray Panel:Endometrium carcinoma tissue microarray, containing 48 cases of adenocarcinoma, single core per case
Cores:48
Cases:48
Layout:8 cols × 6 rows
Core Diameter:2 mm
Thickness:5 µm
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:1. Some slides are covered by a thin layer of paraffin to prevent oxidization and decay, thus are recommended be baked at 56-60°C up to 2 hours until the paraffin melt before doing regular IHC or ISH procedures.
2. For slides not coated with paraffin (those tissue cores can be easily seen on the glass), there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678 
A Ute Ute Ute Ute Ute Ute Ute Ute  
B Ute Ute Ute Ute Ute Ute Ute Ute  
C Ute Ute Ute Ute Ute Ute Ute Ute  
D Ute Ute Ute Ute Ute Ute Ute Ute  
E Ute Ute Ute Ute Ute Ute Ute Ute  
F Ute Ute Ute Ute Ute Ute Ute Ute Marked point
Legend: Ute - Uterus

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIb), - Malignant tumor (stage Ia), - Malignant tumor (stage Ib), - Malignant tumor (stage Ic)

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 60 Uterus Endometrioid adenocarcinoma 1 II T2N0M0 Malignant
A2 2 F 56 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A3 3 F 53 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
A4 4 F 57 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A5 5 F 44 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A6 6 F 50 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
A7 7 F 63 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A8 8 F 65 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B1 9 F 63 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
B2 10 F 50 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B3 11 F 54 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B4 12 F 48 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B5 13 F 50 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
B6 14 F 40 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
B7 15 F 55 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B8 16 F 63 Uterus Endometrioid adenocarcinoma 1 IIb T2bN0M0 Malignant
C1 17 F 33 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C2 18 F 58 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C3 19 F 56 Uterus Endometrioid adenocarcinoma 2 Ia T1aN0M0 Malignant
C4 20 F 68 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C5 21 F 42 Uterus Endometrioid adenocarcinoma 2–3 Ic T1cN0M0 Malignant
C6 22 F 46 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C7 23 F 62 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C8 24 F 52 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D1 25 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D2 26 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D3 27 F 53 Uterus Endometrioid adenocarcinoma (sparse) 1 Ib T1bN0M0 Malignant
D4 28 F 70 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D5 29 F 53 Uterus Endometrioid adenocarcinoma 3 I T1N0M0 Malignant
D6 30 F 54 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
D7 31 F 30 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
D8 32 F 51 Uterus Endometrioid adenocarcinoma – Ib T1bN0M0 Malignant
E1 33 F 43 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E2 34 F 58 Uterus Endometrioid adenocarcinoma (sparse) 2 Ic T1cN0M0 Malignant
E3 35 F 54 Uterus Endometrioid adenocarcinoma 2 II T2N0M0 Malignant
E4 36 F 44 Uterus Endometrioid adenocarcinoma 2 IIIa T3aN0M0 Malignant
E5 37 F 66 Uterus Endometrioid adenocarcinoma 2 IIIa T3aN0M0 Malignant
E6 38 F 51 Uterus Endometrioid adenocarcinoma 2 IIIa T3aN0M0 Malignant
E7 39 F 52 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E8 40 F 70 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F1 41 F 55 Uterus Endometrioid adenocarcinoma 2–3 Ib T1bN0M0 Malignant
F2 42 F 62 Uterus Endometrioid adenocarcinoma 2–3 Ic T1cN0M0 Malignant
F3 43 F 36 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
F4 44 F 43 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
F5 45 F 63 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
F6 46 F 74 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
F7 47 F 55 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
F8 48 F 51 Uterus Endometrioid adenocarcinoma 3 IIIa T3aN0M0 Malignant
– – M 58 Skin Malignant melanoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2010 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal